Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy after natalizumab discontinuation

(2013) Andrew J. Fine et al.   ANNALS OF NEUROLOGY

Interpretation of positive molecular tests of common viruses in the cerebrospinal fluid

(2013) Archana Bhaskaran et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants

(2013) Caroline F. Ryschkewitsch et al.   JOURNAL OF CLINICAL VIROLOGY

Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?

(2013) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Changes to anti-JCV antibody levels in a Swedish national MS cohort

(2013) Clemens Warnke et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

(2013) Stefanie Dahlhaus et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

An assay to quantify species-specific anti-JC virus antibody levels in MS patients

(2013) Clemens Warnke et al.   Multiple Sclerosis Journal

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

(2013) Mike P Wattjes et al.   Multiple Sclerosis Journal

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

(2013) N. Schwab et al.   NEUROLOGY

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis

(2013) C. Warnke et al.   NEUROLOGY

PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section

(2013) J. R. Berger et al.   NEUROLOGY

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

(2012) I. Ayzenberg et al.   JOURNAL OF NEUROLOGY

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies

(2012) Dirk Mentzer et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The effect of plasma exchange on serum anti-JC virus antibodies

(2012) Meena Subramanyam et al.   Multiple Sclerosis Journal

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

(2012) A. K. Trampe et al.   NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

(2011) Imke Metz et al.   ACTA NEUROPATHOLOGICA

Natalizumab and Impedance of the Homing of CD34+ Hematopoietic Progenitors

(2011) Christian Saure   ARCHIVES OF NEUROLOGY

Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome

(2011) Lilian Aly et al.   BRAIN

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

(2011) Ludwig Kappos et al.   LANCET NEUROLOGY

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS

(2011) J. Kuhle et al.   NEUROLOGY

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

(2011) A. Vennegoor et al.   NEUROLOGY

JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab

(2010) Caroline F. Ryschkewitsch et al.   ANNALS OF NEUROLOGY

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

(2010) Clemens Warnke et al.   ANNALS OF NEUROLOGY

Natalizumab and Progressive Multifocal Leukoencephalopathy

(2010) Clemens Warnke et al.   ARCHIVES OF NEUROLOGY

Discrepant findings in immune responses to JC virus in patients receiving natalizumab

(2010) Chen S Tan et al.   LANCET NEUROLOGY

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

(2010) Samantha Jilek et al.   LANCET NEUROLOGY

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus

(2010) Clemens Warnke et al.   Multiple Sclerosis Journal

Swedish natalizumab (Tysabri) multiple sclerosis surveillance study

(2010) Fredrik Piehl et al.   NEUROLOGICAL SCIENCES

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab

(2009) Yiping Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA

(2008) E Iacobaeus et al.   Multiple Sclerosis Journal